Stephan Moll, MD, professor of medicine and member of the UNC Hemophilia and Thrombosis Center, co-authored the results of a large-scale multicenter clinical trial focusing on catheter-directed thrombolysis and its effects.
In August 2017, Pfizer committed to building a $100 million gene therapies plant in North Carolina and, in exchange, North Carolina committed to providing the drugmaker with a quarter-million dollars' worth of help. Pfizer will expand an 11,000-square-foot plant in Sanford, North Carolina that it acquired last year when it bought gene therapies biotech Bamboo Therapeutics in a deal valued at up to $688 million. Bamboo bought the facility last year from the University of North Carolina about the time that Pfizer made its initial investment in the company.
Cure HHT to Present Congressman David E. Price with its "Champion Award" at Launch of Multi-State Pilot Program Headquartered at UNC Chapel Hill
UNC Hemophilia Treatment Center physical therapist Jennifer Newman, PT, MSPT, will moderate and speak at sessions on August 24, 2017 and August 25, 2017 at the National Hemophilia Foundation annual meeting in Chicago.
The HHT International Scientific Conference is held every other year. It is the premier conference on HHT, and over 250 basic and clinical researchers from around the world attend and present their work. The 12th HHT International Scientific Conference was held from June 8-11, 2017 in Dubrovnik.
The 9th Symposium on Hemostasis, "Advances in the Clinical and Basic Sciences of Coagulation," will be held April 12-14, 2018, in Chapel Hill, North Carolina.
UNC-Chapel Hill Drs. Nigel Key and Alisa Wolberg were featured in a recent ASH video about thrombosis research.
Dr. Nigel Key, Professor of Medicine and Pathology, Chief of the Section of Classical Hematology, and the Director of the UNC Hemophilia and Thrombosis Center, was a keynote speaker at the annual Earl W. Davie Symposium in Vancouver, BC on November 17, 2016.
Dr. Abajas received a two-year award (July 1, 2016 - June 30, 2018) to support clinical and research training in bleeding and clotting disorders.
The International Society on Thrombosis and Hemostasis will hold its Advanced Training Course in Thrombosis and Hemostasis in Atlanta, Georgia, November 1-4, 2016. UNC Hemophilia and Thrombosis Center Director Nigel Key, M.D., is chairing and speaking, and UNC physician Stephan Moll, M.D., is speaking as well.